PMBS is ripe for a R/M.. A clean shell with little debt compared to most. PLKD had much more debt with a huge O/S and still made it to .40.. I have found no proof that the Lipigesic patent expired.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.